Advanced Glaucoma Intervention Study (AGIS)

Status unconfirmed · Phase 3

Conditions studied: Glaucoma

In brief

To assess the long-range outcomes of sequences of interventions involving trabeculectomy and argon laser trabeculoplasty in eyes that have failed initial medical treatment for glaucoma.

Key facts

Study ID

NCT00000148

Run by

National Eye Institute (NEI)

Starts

1988-04-01

Last updated by the study team

2006-06-05

Who can join

Age: 35 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Yale University School of Medicine, Yale Eye Center — New Haven, Connecticut, United States
• Georgetown University, University Ophthalmic Consultants of Washington, Eye Associates of Washington, D.C. — Washington D.C., District of Columbia, United States
• Emory University, Emory Eye Center — Atlanta, Georgia, United States
• Piedmont Hospital, Eye Consultants of Atlanta — Atlanta, Georgia, United States
• Humana Health Plan Sykes Center — Chicago, Illinois, United States
• University of Illinois, Eye and Ear Infirmary — Chicago, Illinois, United States
• Washington Hospital Center, Washington Eye Physicians and Surgeons — Chevy Chase, Maryland, United States
• University of Michigan, W.K. Kellogg Eye Center — Ann Arbor, Michigan, United States
• Sinai Hospital, Detroit, Franklin Eye Consultants — Southfield, Michigan, United States
• Ohio State University, Department of Ophthalmology, Ophthalmic Surgeons and Consultants — Columbus, Ohio, United States
• Wills Eye Hospital, Glaucoma Service — Philadelphia, Pennsylvania, United States
• University of Virginia Medical Center, Department of Ophthalmology — Charlottesville, Virginia, United States
• Medical College of Virginia, Department of Ophthalmology — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.